Skip to main content
Addgene
Showing: 61 - 78 of 78 results
  1. pAAV-hSyn-EGFP (AAV1 trial size)

    Viral Prep
    #50465-AAV1.T
    Purpose
    Ready-to-use AAV1 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EGFP
    Available since
    July 12, 2019
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-CaMKIIa-EGFP (AAV Retrograde)

    Viral Prep
    #50469-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Sept. 13, 2021
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV8)

    Viral Prep
    #50476-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    Oct. 26, 2016
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV2)

    Viral Prep
    #50476-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    Jan. 26, 2021
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-CaMKIIa-EGFP (AAV8)

    Viral Prep
    #50469-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Nov. 8, 2016
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-CaMKIIa-hM4D(Gi)-mCherry (AAV2)

    Viral Prep
    #50477-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-hM4D(Gi)-mCherry (#50477). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM4D(Gi)-mCherry plasmid DNA. CaMKIIa-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    March 12, 2021
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV9)

    Viral Prep
    #50476-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    Jan. 26, 2021
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV-hSyn-EGFP (AAV2 trial size)

    Viral Prep
    #50465-AAV2.T
    Purpose
    Ready-to-use AAV2 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EGFP
    Available since
    July 31, 2019
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-hSyn-DIO-rM3D(Gs)-mCherry (AAV8)

    Viral Prep
    #50458-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-hSyn-DIO-rM3D(Gs)-mCherry (#50458). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-rM3D(Gs)-mCherry plasmid DNA. hSyn-driven, Cre-dependent rM3D(Gs) receptor with an mCherry reporter for chemogenetic excitation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-CaMKIIa-EGFP (AAV1)

    Viral Prep
    #50469-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-hSyn-hM4D(Gi)-mCherry (AAV1)

    Viral Prep
    #50475-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-hM4D(Gi)-mCherry (#50475). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM4D(Gi)-mCherry plasmid DNA. hSyn-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry
    Available since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-hSyn-EGFP (AAV5 trial size)

    Viral Prep
    #50465-AAV5.T
    Purpose
    Ready-to-use AAV5 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EGFP
    Available since
    June 12, 2019
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-CaMKIIa-HA-hM4D(Gi)-IRES-mCitrine (AAV8)

    Viral Prep
    #50467-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-HA-hM4D(Gi)-IRES-mCitrine (#50467). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-HA-hM4D(Gi)-IRES-mCitrine plasmid DNA. CaMKIIa-driven HA-tagged hM4D(Gi) and bicistronic mCitrine expression, for chemogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCitrine
    Available since
    May 29, 2020
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-hSyn-hM3D(Gq)-mCherry (AAV1)

    Viral Prep
    #50474-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-hM3D(Gq)-mCherry (#50474). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM3D(Gq)-mCherry plasmid DNA. hSyn-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry
    Available since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV CD68-hM4D(Gi)-mCherry (AAV1)

    Viral Prep
    #75033-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CD68
    Tags
    mCherry
    Available since
    March 27, 2019
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine (AAV5)

    Viral Prep
    #50472-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine (#50472). In addition to the viral particles, you will also receive purified pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine plasmid DNA. GFAP-driven HA-tagged rM3D(Gs) and bicistronic mCitrine expression, for chemogenetic excitation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCitrine
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV CD68-hM4D(Gi)-mCherry (AAV9)

    Viral Prep
    #75033-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CD68
    Tags
    mCherry
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV-CaMKIIa-EGFP (AAV2)

    Viral Prep
    #50469-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
Showing: 61 - 78 of 78 results